<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>British journal of pharmacology[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/British_journal_of_pharmacology</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925493/full_citation/Pharmacokinetics_and_pharmacodynamics_of_a_new_reformulated_microemulsion_and_the_long_chain_triglyceride_emulsion_of_propofol_in_beagle_dogs_</link><description>Lee SH, Ghim JL, Song MH, et al. <br/><span class="title">Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925493/abstract/Pharmacokinetics_and_pharmacodynamics_of_a_new_reformulated_microemulsion_and_the_long_chain_triglyceride_emulsion_of_propofol_in_beagle_dogs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925493/full_citation/Pharmacokinetics_and_pharmacodynamics_of_a_new_reformulated_microemulsion_and_the_long_chain_triglyceride_emulsion_of_propofol_in_beagle_dogs_">Full Citation</a></description></item><item><title>Characterization of biosynthesis and modes of action of prostaglandin E(2) and prostacyclin in guinea pig mesenteric lymphatic vessels.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922540/full_citation/Characterization_of_biosynthesis_and_modes_of_action_of_prostaglandin_E_2__and_prostacyclin_in_guinea_pig_mesenteric_lymphatic_vessels_</link><description>Rehal S, Blanckaert P, Roizes S, et al. <br/><span class="title">Characterization of biosynthesis and modes of action of prostaglandin E(2) and prostacyclin in guinea pig mesenteric lymphatic vessels. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922540/abstract/Characterization_of_biosynthesis_and_modes_of_action_of_prostaglandin_E_2__and_prostacyclin_in_guinea_pig_mesenteric_lymphatic_vessels_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922540/full_citation/Characterization_of_biosynthesis_and_modes_of_action_of_prostaglandin_E_2__and_prostacyclin_in_guinea_pig_mesenteric_lymphatic_vessels_">Full Citation</a></description></item><item><title>Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922539/full_citation/Berry_anthocyanins_and_anthocyanidins_exhibit_distinct_affinities_for_the_efflux_transporters_BCRP_and_MDR1_</link><description>Dreiseitel A, Oosterhuis B, Vukman K, et al. <br/><span class="title">Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922539/abstract/Berry_anthocyanins_and_anthocyanidins_exhibit_distinct_affinities_for_the_efflux_transporters_BCRP_and_MDR1_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922539/full_citation/Berry_anthocyanins_and_anthocyanidins_exhibit_distinct_affinities_for_the_efflux_transporters_BCRP_and_MDR1_">Full Citation</a></description></item><item><title>The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922538/full_citation/The_benzoxathiolone_LYR_71_down_regulates_interferon_gamma_inducible_pro_inflammatory_genes_by_uncoupling_tyrosine_phosphorylation_of_STAT_1_in_macrophages_</link><description>Chung EY, Kim BH, Lee IJ, et al. <br/><span class="title">The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922538/abstract/The_benzoxathiolone_LYR_71_down_regulates_interferon_gamma_inducible_pro_inflammatory_genes_by_uncoupling_tyrosine_phosphorylation_of_STAT_1_in_macrophages_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922538/full_citation/The_benzoxathiolone_LYR_71_down_regulates_interferon_gamma_inducible_pro_inflammatory_genes_by_uncoupling_tyrosine_phosphorylation_of_STAT_1_in_macrophages_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922538/The_benzoxathiolone_LYR_71_down_regulates_interferon_gamma_inducible_pro_inflammatory_genes_by_uncoupling_tyrosine_phosphorylation_of_STAT_1_in_macrophages_">Find Related Articles</a> </description></item><item><title>Phe369(7.38) at human 5-HT receptors confers interspecies selectivity to antagonists and partial agonists.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922537/full_citation/Phe369_7_38__at_human_5_HT_receptors_confers_interspecies_selectivity_to_antagonists_and_partial_agonists_</link><description>Varin T, Gutiérrez-de-Terán H, Castro M, et al. <br/><span class="title">Phe369(7.38) at human 5-HT receptors confers interspecies selectivity to antagonists and partial agonists. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922537/abstract/Phe369_7_38__at_human_5_HT_receptors_confers_interspecies_selectivity_to_antagonists_and_partial_agonists_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922537/full_citation/Phe369_7_38__at_human_5_HT_receptors_confers_interspecies_selectivity_to_antagonists_and_partial_agonists_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922537/Phe369_7_38__at_human_5_HT_receptors_confers_interspecies_selectivity_to_antagonists_and_partial_agonists_">Find Related Articles</a> </description></item><item><title>The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922536/full_citation/The_thorough_QT/QTc_study_4_years_after_the_implementation_of_the_ICH_E14_guidance_</link><description>Darpo B <br/><span class="title">The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922536/abstract/The_thorough_QT/QTc_study_4_years_after_the_implementation_of_the_ICH_E14_guidance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922536/full_citation/The_thorough_QT/QTc_study_4_years_after_the_implementation_of_the_ICH_E14_guidance_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922536/The_thorough_QT/QTc_study_4_years_after_the_implementation_of_the_ICH_E14_guidance_">Find Related Articles</a> </description></item><item><title>Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922535/full_citation/Therapeutic_potential_for_novel_drugs_targeting_the_type_1_cholecystokinin_receptor_</link><description>Cawston EE, Miller LJ <br/><span class="title">Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922535/abstract/Therapeutic_potential_for_novel_drugs_targeting_the_type_1_cholecystokinin_receptor_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922535/full_citation/Therapeutic_potential_for_novel_drugs_targeting_the_type_1_cholecystokinin_receptor_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922535/Therapeutic_potential_for_novel_drugs_targeting_the_type_1_cholecystokinin_receptor_">Find Related Articles</a> </description></item><item><title>Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917067/full_citation/Dual_effect_of_the_novel_peptide_antagonist_K_14585_on_proteinase_activated_receptor_2_mediated_signalling_</link><description>Goh FG, Ng PY, Nilsson M, et al. <br/><span class="title">Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917067/abstract/Dual_effect_of_the_novel_peptide_antagonist_K_14585_on_proteinase_activated_receptor_2_mediated_signalling_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917067/full_citation/Dual_effect_of_the_novel_peptide_antagonist_K_14585_on_proteinase_activated_receptor_2_mediated_signalling_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1476-5381.2009.00415.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917067/Dual_effect_of_the_novel_peptide_antagonist_K_14585_on_proteinase_activated_receptor_2_mediated_signalling_">Find Related Articles</a> </description></item><item><title>Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917066/full_citation/Rosiglitazone_via_upregulation_of_Akt/eNOS_pathways_attenuates_dysfunction_of_endothelial_progenitor_cells_induced_by_advanced_glycation_end_products_</link><description>Liang C, Ren Y, Tan H, et al. <br/><span class="title">Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917066/abstract/Rosiglitazone_via_upregulation_of_Akt/eNOS_pathways_attenuates_dysfunction_of_endothelial_progenitor_cells_induced_by_advanced_glycation_end_products_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917066/full_citation/Rosiglitazone_via_upregulation_of_Akt/eNOS_pathways_attenuates_dysfunction_of_endothelial_progenitor_cells_induced_by_advanced_glycation_end_products_">Full Citation</a></description></item><item><title>Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917065/full_citation/Dalcetrapib:_no_off_target_toxicity_on_blood_pressure_or_on_genes_related_to_the_renin_angiotensin_aldosterone_system_in_rats_</link><description>Stroes ES, Kastelein JJ, Bénardeau A, et al. <br/><span class="title">Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of pharmacology">Br J Pharmacol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917065/abstract/Dalcetrapib:_no_off_target_toxicity_on_blood_pressure_or_on_genes_related_to_the_renin_angiotensin_aldosterone_system_in_rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917065/full_citation/Dalcetrapib:_no_off_target_toxicity_on_blood_pressure_or_on_genes_related_to_the_renin_angiotensin_aldosterone_system_in_rats_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917065/Dalcetrapib:_no_off_target_toxicity_on_blood_pressure_or_on_genes_related_to_the_renin_angiotensin_aldosterone_system_in_rats_">Find Related Articles</a> </description></item></channel></rss>